Liminatus Pharma, Inc. (NASDAQ:LIMN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nicholas Fernandez Other companies: JATT III Acquisition Corp (Director · Since at least Aug 25, 2026); Amanat Acquisition Corp (Chief Financial Officer · Since at least May 18, 2026); JATT II Acquisition Corp (Chief Financial Officer · Since at least Apr 16, 2026) | Director · Apr 30, 2025 – Apr 30, 2025 · Past |
| Beom Kyu Choi | Chief Technology Officer · Apr 30, 2025 – Apr 30, 2025 · Past |
| Byong Chul Yoo | Chief Science Officer · Apr 30, 2025 – Apr 30, 2025 · Past |
| Chris Kim | Chief Executive Officer, Director · Since at least Apr 30, 2025 |
| Chris Kim | CEO · Since at least Aug 24, 2026 |
| Eun Sook Lee | Director · Apr 30, 2025 – Apr 30, 2025 · Past |
| Ji Yeon Baek | Director · Apr 30, 2025 – Apr 30, 2025 · Past |
| Philip Wayne Lemons II | Director · Since at least Jul 10, 2025 |
| Richard JaiHwan Baek | Director · Since at least Jul 10, 2025 |
| Sang-Jin Lee | Head of Research & Development · Apr 30, 2025 – Apr 30, 2025 · Past |
| Scott Dam | Chief Financial Officer · Apr 30, 2025 – Apr 30, 2025 · Past |